Hye Jin Wang

626 total citations
14 papers, 503 citations indexed

About

Hye Jin Wang is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hye Jin Wang has authored 14 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hye Jin Wang's work include Lipoproteins and Cardiovascular Health (5 papers), Diabetes Treatment and Management (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Hye Jin Wang is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Diabetes Treatment and Management (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Hye Jin Wang collaborates with scholars based in South Korea, United States and Australia. Hye Jin Wang's co-authors include Eun Seok Kang, Bong Soo, Yong‐ho Lee, Byung‐Wan Lee, Gyuri Kim, Myung‐Shik Lee, Soo Hyun Kim, Mijin Yun, Chul Woo Ahn and Eun Yeong Choe and has published in prestigious journals such as PLoS ONE, Scientific Reports and Transplantation.

In The Last Decade

Hye Jin Wang

14 papers receiving 496 citations

Peers

Hye Jin Wang
Yonghee Lee South Korea
Hye Jin Wang
Citations per year, relative to Hye Jin Wang Hye Jin Wang (= 1×) peers Yonghee Lee

Countries citing papers authored by Hye Jin Wang

Since Specialization
Citations

This map shows the geographic impact of Hye Jin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye Jin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye Jin Wang more than expected).

Fields of papers citing papers by Hye Jin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye Jin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye Jin Wang. The network helps show where Hye Jin Wang may publish in the future.

Co-authorship network of co-authors of Hye Jin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hye Jin Wang. A scholar is included among the top collaborators of Hye Jin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye Jin Wang. Hye Jin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Cho, Yongin, et al.. (2020). Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue. Biomedicines. 8(11). 512–512. 17 indexed citations
2.
Choi, Hoon Young, Hye Jin Wang, Eun Seok Kang, et al.. (2019). Reduced expression of pyruvate kinase in kidney proximal tubule cells is a potential mechanism of pravastatin altered glucose metabolism. Scientific Reports. 9(1). 5318–5318. 5 indexed citations
3.
Kim, Jin Hee, Hae Young Ko, Hye Jin Wang, et al.. (2019). Effect of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on gluconeogenesis in proximal renal tubules. Diabetes Obesity and Metabolism. 22(3). 373–382. 28 indexed citations
4.
Cho, Yongin, et al.. (2019). Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, <i>in vitro</i> and <i>in vivo </i>. Journal of Atherosclerosis and Thrombosis. 27(5). 429–440. 5 indexed citations
5.
Kim, Soo Hyun, Gyuri Kim, Dai Hoon Han, et al.. (2017). Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Autophagy. 13(10). 1767–1781. 179 indexed citations
6.
Han, Eugene, Gyuri Kim, Yong‐ho Lee, et al.. (2016). Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia. PLoS ONE. 11(5). e0154683–e0154683. 41 indexed citations
7.
Bae, Jaehyun, Min Jung Lee, Eun Yeong Choe, et al.. (2016). Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study. Endocrinology and Metabolism. 31(1). 161–161. 21 indexed citations
8.
Kim, Gyuri, Kwang Joon Kim, Yong‐ho Lee, et al.. (2015). Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes. Cardiovascular Diabetology. 14(1). 148–148. 35 indexed citations
9.
Wang, Hye Jin, Obin Kwon, Eun Yeong Choe, et al.. (2015). Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction. Autophagy. 11(11). 2089–2101. 43 indexed citations
10.
Cho, Yongin, Yong‐ho Lee, YounJeong Choi, et al.. (2014). Risk of diabetes in patients treated with HMG-CoA reductase inhibitors. Metabolism. 64(4). 482–488. 54 indexed citations
11.
Choe, Eun Yeong, Yongin Cho, YounJeong Choi, et al.. (2014). The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes. Diabetes & Metabolism Journal. 38(3). 211–211. 25 indexed citations
12.
Choe, Eun Yeong, Hye Jin Wang, Obin Kwon, et al.. (2013). HMG CoA Reductase Inhibitor Treatment Induces Dysglycemia in Renal Allograft Recipients. Transplantation. 97(4). 419–425. 9 indexed citations
13.
Choe, Eun Yeong, Hye Jin Wang, Obin Kwon, et al.. (2012). Variants of the Adiponectin Gene and Diabetic Microvascular Complications in Patients with Type 2 Diabetes. Metabolism. 62(5). 677–685. 24 indexed citations
14.
Wang, Hye Jin, Seung Jin Han, Soo Hyun Kim, et al.. (2011). Dual pathways of p53 mediated glucolipotoxicity-induced apoptosis of rat cardiomyoblast cell: activation of p53 proapoptosis and inhibition of Nrf2-NQO1 antiapoptosis. Metabolism. 61(4). 496–503. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026